Best cases from the AFIP: Metastatic renal cell carcinoma

Radiographics

Volumn 27, Issue 6, 2007, Pages 1801-1807

  Lin, Shao Pow ^a   Bierhals, Andrew J ^a   Lewis Jr , James S ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 36849084167     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.276075013     Document Type: Article

References (19)

1. Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. RadioGraphics 2001;21(spec no):S237-S254.
2. Volpe A, Jewett MA. The natural history of small renal masses. Nat Clin Pract Urol 2005;2:384-390.
3. Prasad SR, Humphrey PA, Catena JR, et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. RadioGraphics 2006;26:1795-1806; discussion 1806-1810.
4. Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000;24:835-842.
5. Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 2002;178:1499-1506.
6. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005;353:2477-2490.
7. Jones J, Libermann TA. Genomics of renal cell cancer: the biology behind and the therapy ahead. Clin Cancer Res 2007;13(2 pt 2):685s-692s.
8. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS. Renal cell carcinoma 2005: new frontiers in staging, prognostication, and targeted molecular therapy. J Urol 2005;173:1853-1862.
9. Brant W, Helms C. Fundamentals of diagnostic radiology. Philadelphia, Pa: Lippincott, Williams & Wilkins, 1999.
10. Jadvar H, Kherbache HM, Pinski JK, Conti PS. Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma. Clin Nephrol 2003;60:395-400.
11. Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004;171:1806-1809.
12. Majhail NS, Urbain JL, Albani JM, et al. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 2003;21:3995-4000.
13. Ramdave S, Thomas GW, Berlangieri SU, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001;166:825-830.
14. Ak I, Can C. F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol 2005;46:895-899.
15. Cherng SC, Chang CY, Fan YM, Chen CY, Chiu CS, Cheng CY. CT with anatomic delineation identifying renal cell carcinoma with normal metabolic activity on F-18 FDG PET imaging. Clin Nucl Med 2006;31:490-491.
16. Kim J. Imaging findings of renal cell carcinoma. Expert Rev Anticancer Ther 2006;6:895-904.
17. Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 1997;205:103-107.
18. Ficarra V, Righetti R, Pilloni S, et al. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur Urol 2002;41:190-198.
19. Motzer RJ, Rini BI, Bukowski RM, et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006;295:2516-2524.